These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 24295151)

  • 1. The thioredoxin reductase-1 inhibitor aurothioglucose attenuates lung injury and improves survival in a murine model of acute respiratory distress syndrome.
    Britt RD; Velten M; Locy ML; Rogers LK; Tipple TE
    Antioxid Redox Signal; 2014 Jun; 20(17):2681-91. PubMed ID: 24295151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thioredoxin Reductase-1 Inhibition Augments Endogenous Glutathione-Dependent Antioxidant Responses in Experimental Bronchopulmonary Dysplasia.
    Wall SB; Wood R; Dunigan K; Li Q; Li R; Rogers LK; Tipple TE
    Oxid Med Cell Longev; 2019; 2019():7945983. PubMed ID: 30805084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioredoxin Reductase Inhibition Attenuates Neonatal Hyperoxic Lung Injury and Enhances Nuclear Factor E2-Related Factor 2 Activation.
    Li Q; Wall SB; Ren C; Velten M; Hill CL; Locy ML; Rogers LK; Tipple TE
    Am J Respir Cell Mol Biol; 2016 Sep; 55(3):419-28. PubMed ID: 27089175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thioredoxin reductase inhibition elicits Nrf2-mediated responses in Clara cells: implications for oxidant-induced lung injury.
    Locy ML; Rogers LK; Prigge JR; Schmidt EE; Arnér ES; Tipple TE
    Antioxid Redox Signal; 2012 Nov; 17(10):1407-16. PubMed ID: 22607006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aurothioglucose enhances proangiogenic pathway activation in lungs from room air and hyperoxia-exposed newborn mice.
    Dunigan-Russell K; Lin V; Silverberg M; Wall SB; Li R; Gotham J; Nicola T; Sridharan A; Snowball J; Delaney C; Li Q; Tipple TE
    Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1165-L1171. PubMed ID: 32292070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioredoxin-related mechanisms in hyperoxic lung injury in mice.
    Tipple TE; Welty SE; Rogers LK; Hansen TN; Choi YE; Kehrer JP; Smith CV
    Am J Respir Cell Mol Biol; 2007 Oct; 37(4):405-13. PubMed ID: 17575077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aurothioglucose does not improve alveolarization or elicit sustained Nrf2 activation in C57BL/6 models of bronchopulmonary dysplasia.
    Li Q; Li R; Wall SB; Dunigan K; Ren C; Jilling T; Rogers LK; Tipple TE
    Am J Physiol Lung Cell Mol Physiol; 2018 May; 314(5):L736-L742. PubMed ID: 29368550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liraglutide pretreatment attenuates sepsis-induced acute lung injury.
    Baer B; Putz ND; Riedmann K; Gonski S; Lin J; Ware LB; Toki S; Peebles RS; Cahill KN; Bastarache JA
    Am J Physiol Lung Cell Mol Physiol; 2023 Sep; 325(3):L368-L384. PubMed ID: 37489855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose.
    Du Y; Zhang H; Lu J; Holmgren A
    J Biol Chem; 2012 Nov; 287(45):38210-9. PubMed ID: 22977247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long term normobaric hyperoxia exposure on lipopolysaccharide-induced lung injury.
    Ha JH; Kim SW; Kim IK; Yeo CD; Kang HH; Lee SH
    Exp Lung Res; 2020; 46(1-2):44-52. PubMed ID: 32067505
    [No Abstract]   [Full Text] [Related]  

  • 11. Nitrated fatty acid, 10-nitrooleate protects against hyperoxia-induced acute lung injury in mice.
    Narala VR; Thimmana LV; Panati K; Kolliputi N
    Int Immunopharmacol; 2022 Aug; 109():108838. PubMed ID: 35561478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutathione reductase targeted to type II cells does not protect mice from hyperoxic lung injury.
    Heyob KM; Rogers LK; Welty SE
    Am J Respir Cell Mol Biol; 2008 Dec; 39(6):683-8. PubMed ID: 18566333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic characteristics of alveolar-like macrophages in mouse models of hyperoxia and LPS-induced lung inflammation.
    Litman K; Bouch S; Litvack ML; Post M
    Am J Physiol Lung Cell Mol Physiol; 2024 Sep; 327(3):L269-L281. PubMed ID: 38887793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetylcysteine does not protect against type II cell injury after prolonged exposure to hyperoxia in rats.
    van Klaveren RJ; Dinsdale D; Pype JL; Demedts M; Nemery B
    Am J Physiol; 1997 Sep; 273(3 Pt 1):L548-55. PubMed ID: 9316488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogen gas reduces hyperoxic lung injury via the Nrf2 pathway in vivo.
    Kawamura T; Wakabayashi N; Shigemura N; Huang CS; Masutani K; Tanaka Y; Noda K; Peng X; Takahashi T; Billiar TR; Okumura M; Toyoda Y; Kensler TW; Nakao A
    Am J Physiol Lung Cell Mol Physiol; 2013 May; 304(10):L646-56. PubMed ID: 23475767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small Immunomodulatory Molecules as Potential Therapeutics in Experimental Murine Models of Acute Lung Injury (ALI)/Acute Respiratory Distress Syndrome (ARDS).
    Shah D; Das P; Acharya S; Agarwal B; Christensen DJ; Robertson SM; Bhandari V
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triptolide dose-dependently improves LPS-induced alveolar hypercoagulation and fibrinolysis inhibition through NF-κB inactivation in ARDS mice.
    Yang H; Qian H; Liu B; Wu Y; Cheng Y; Zheng X; Li X; Yang G; He T; Li S; Shen F
    Biomed Pharmacother; 2021 Jul; 139():111569. PubMed ID: 34243622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen-mediated lung injury in mice lacking the gene for NRF2: Rescue with the cytochrome P4501A-inducer, beta-naphthoflavone (BNF), and differential sex-specific effects.
    Callaway DA; Jiang W; Wang L; Lingappan K; Moorthy B
    Free Radic Biol Med; 2020 Nov; 160():208-218. PubMed ID: 32791187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Pendrin by a small molecule reduces Lipopolysaccharide-induced acute Lung Injury.
    Lee EH; Shin MH; Gi M; Park J; Song D; Hyun YM; Ryu JH; Seong JK; Jeon Y; Han G; Namkung W; Park MS; Choi JY
    Theranostics; 2020; 10(22):9913-9922. PubMed ID: 32929324
    [No Abstract]   [Full Text] [Related]  

  • 20. Astaxanthin Prevents Lung Injury Due to Hyperoxia and Inflammation.
    Akduman H; Tayman C; Çakir U; Çakir E; Dilli D; Türkmenoğlu TT; Gönel A
    Comb Chem High Throughput Screen; 2021; 24(8):1243-1250. PubMed ID: 32933455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.